Factors contributing to the ramifications of this disease as it stands include the socio-economic: overweight and obesity ...

Boston Scientific apparently knows a good bet when it sees one. | That includes treating more than 200,000 patients with the ...

Medical device maker Boston Scientific forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices. Manufacturers of medical devices have been ...

Minnesota system treating atrial fibrillation helped sustain Boston Scientific’s streak of bullish results as the company ...

Boston Scientific posted Q4 revenue of $4.56 billion, surpassing estimates. The company forecasts 2025 sales growth of up to 14.5% and EPS of $2.80-$2.87.

Boston Scientific Corporation ( NYSE: BSX) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ET Jonathan Monson - SVP, IR Michael Mahoney - Chairman and CEO Daniel Brennan - EVP and CFO ...

The company primarily operates through its MedSurg (endoscopy, urology ... there’s a powerful fundamental story happening with Boston Scientific. Also, EPS is estimated to ramp higher this ...

The headline numbers for Boston Scientific (BSX) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 82 tables and 82 figures, this 175-page report ?Global Endoscopy Devices Market 2023-2033 by Device Type, Hygiene, ...